Sex differences in the GSK3β-mediated survival of adherent leukemic progenitors. (Q51442692)

5 April 2018

title

Sex differences in the GSK3β-mediated survival of adherent leukemic progenitors. (English)

1 reference

5 April 2018

1 reference

Véronique Maguer-Satta

object named as

V Maguer-Satta

9

0 references

Nathalie Vergnolle

object named as

N Vergnolle

10

0 references

author name string

J Bertrand

1

1 reference

5 April 2018

M Despeaux

2

1 reference

5 April 2018

S Joly

3

1 reference

5 April 2018

E Bourogaa

4

1 reference

5 April 2018

N Gallay

5

1 reference

5 April 2018

C Demur

6

1 reference

5 April 2018

P Bonnevialle

7

1 reference

5 April 2018

F Louache

8

1 reference

5 April 2018

B Payrastre

11

1 reference

5 April 2018

C Racaud-Sultan

12

1 reference

5 April 2018

language of work or name

English

0 references

publication date

4 July 2011

1 reference

5 April 2018

published in

Oncogene

1 reference

5 April 2018

volume

31

1 reference

5 April 2018

issue

6

1 reference

5 April 2018

page(s)

694-705

1 reference

5 April 2018

https://scigraph.springernature.com/pub.10.1038/onc.2011.258

exact match

0 references

cites work

TLR7 ligands induce higher IFN-alpha production in females.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Functional mapping of the promoter region of the GNB2L1 human gene coding for RACK1 scaffold protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

A New alpha5beta1 integrin-dependent survival pathway through GSK3beta activation in leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Biology of normal and acute myeloid leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Insulin-like growth factor-I receptor mediates the prosurvival effect of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Integrin alpha 2 beta 1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and beta1 integrin and for tumor cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Functional proteomic profiling of AML predicts response and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the alpha interferon receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Tumor microenvironment and drug resistance in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Systemic signals regulate ageing and rejuvenation of blood stem cell niches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer's d

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Inflammation-dependent alpha 5 beta 1 (very late antigen-5) expression on leukocytes reveals a functional role for this integrin in acute peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Identification of an antiapoptotic protein complex at death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

mTOR regulates cell survival after etoposide treatment in primary AML cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Critical features of FAK-expressing AML bone marrow microenvironment through leukemia stem cell hijacking of mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

Abundant expression of fibronectin is a major feature of leukemic dendritic cells differentiated from patients with acute myeloid leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.258

31 March 2020

Identifiers

DOI

10.1038/ONC.2011.258

1 reference

5 April 2018

PubMed ID

21725365

1 reference

5 April 2018